Telix Pharmaceuticals Ltd reported 344.11M in Ordinary Share Capital for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Cochlear COH:AU $ 1.28B 0
Integral Diagnostics Ltd IDX:AU 322.54M 88.01M
Mayne Pharma MYX:AU $ 1.24B 0
Opthea Ltd OPT:AU 323.19M 89.05M
Pacific Edge PEB:NZ 294.14M 26.44M
Paradigm Biopharmaceuticals Ltd PAR:AU 147.19M 125.8K
Polynovo Ltd PNV:AU 139.43M 180K
PYC Therapeutics Ltd PYC:AU 125.99M 0
Ramsay Health Care RHC:AU $ 2.2B 0
ResMed RMD:AU $ 849.16K 264.16K
Sonic Healthcare SHL:AU $ 3.86B 283.06M